Hidayat Arifin is a faculty member of the Faculty of Nursing, Universitas Padjadjaran, Indonesia. He works as a researcher, academic editor, and reviewer in national and international journals. His research interests and area of expertise include medical-surgical nursing, adult nursing, non-communicable diseases, and secondary data analysis in healthcare.
Josh is a clinician researcher, and divides his time between clinical work as an Infectious Diseases physician in Newcastle, and research work as a principal research fellow based at Menzies.
He completed his clinical infectious diseases training in 2004, and then worked on a PhD from 2007-2010 on the epidemiology, pathophysiology and adjunctive treatment of sepsis in the Top End of the Northern Territory (NT).
His main clinical interests are general infectious diseases, viral hepatitis, refugee health and infections in the critical care setting. His main research interests are clinical trials in the management of severe infections and epidemiology of severe bacterial infections.
Josh is the past president of the Australasian Society for Infectious Diseases (ASID) and is a career development fellow of Australia's National Health and Medical Research Council. In the 10 years since completing his PhD, he has over 140 peer-reviewed publications and an h-index of 31.
Dr. Tamàs Fülöp is Assistant Director of the Age Research Centre and Full Professor within the Faculty of Medicine and Health Sciences at the Université de Sherbrooke in Quebec, Canada. He is also Head of the Immune Inflammation Laboratory and Medical Director of the Memory Clinic.
M.D: From the Unversity of Geneva.
His postdoctoral research was in the biochemistry of connective tissues, and his PhD is in immunology and gerontology. His research interest is aging in relation to immunity.
Dr. Lei Huang is a cancer epidemiologist, translational oncologist, digestive surgeon, surgical oncologist, and gastroenterologist. He has published about 50 papers in SCI(E)-indexed journals including Gut, Annals of Surgery, BMC Medicine, JAMA Surgery, Clinical Cancer Research, Cancer Immunology Research, International Journal of Cancer, EBioMedicine, and Gastric Cancer. His works have been cited for about 1000 times.
Dr. Huang has served on the editorial board of Frontiers in Oncology, World Journal of Gastrointestinal Oncology, PeerJ, Medicine, and Translational Cancer Research, and Frontiers in Surgery. He has been peer reviewer for about 50 SCI(E)-indexed journals including Annals of Internal Medicine, Annals of Surgery, Clinical Cancer Research, Journal of the National Comprehensive Cancer Network-JNCCN, Cancer Letters, Oncoimmunology, and Oncologist. He was selected as Best Reviewer for Annals of Internal Medicine twice in 2017 and 2019.
Dr. Huang has been invited to give oral presentations in the ASCO Annual Meeting and International Gastric Cancer Congress (IGCC), and has received Merit Awards in the ESMO Annual Meeting and Awards for Young Investigators in the IGCC.
His research interests majorly cover the epidemiological, clinical, and translational aspects of digestive cancers. He has successfully coordinated several large international investigations with participants from the US and about 20 European countries.
Professor and Director of the Degenerative Diseases at the Sanford-Burnham Medical Research Institute, La Jolla, CA. Formerly Professor of Biological Chemistry and Internal Medicine and Investigator of the Howard Hughes Medical Research Institute at the University of Michigan Medical School. Awards include the Murray Thelin Award, the ìPrix Henri Chaigneauî, the ISTH Investigator Recognition Award , the ESACT Van Wezel Prize, and fellow of the AAAS.
Dr. Yusra Habib Khan is an Assistant Professor in the Department of Clinical Pharmacy at Jouf University, Saudi Arabia. She received her PhD in Clinical Pharmacy from Universiti Sains Malaysia (USM).
Dr Yusra’s research expertise includes vaccine hesitancy, clinical outcomes among chronic kidney disease patients, pharmaceutical care, pharmacoepidemiology, pharmacovigilance and viral infections, the latter of which can be observed in her recent articles published on COVID-19. Dr Yusra’s current research has significantly contributed to ascertaining the atypical complications, particularly nephropathies in various infectious diseases.
Dr. Yusra`s has published more than 100 scholarly articles in well-reputed scientific journals and her work has been cited more than 1500 times with a h-index of 21. She has also published one book entitled: “Expanded Dengue Syndrome” and various chapters with reputable publishers.
Dr. Yusra has gained teaching experience in Malaysia, Pakistan, and Saudi Arabia, and is responsible for the supervision of postgraduate students. She leads various funded projects in the field of health sciences, and based on her significant scientific contributions in the field of Pharmaceutical and medical sciences, she has been awarded several awards (Best Researcher and Best Presenter).
Prof. Marunaka is the Representative Director, Director of Clinical, and Director of Medical Research Institute, Kyoto Industrial Health Association; Professor, Research Center for Drug Discovery and Pharmaceutical Development, Ritsumeikan University; Jinshan Distinguished Professor, International Research Center for Food Nutrition and Safety, Jiangsu University; Professor Emeritus, Kyoto Prefectural University of Medicine; President, Physiological Society of Japan. MD (1979), PhD (1985), Kyoto Prefectural University of Medicine; National License of Physician and Surgeon, Japan (1979). He was Professor and Chairperson, Departments of Molecular Cell Physiology and Bio-Ionomics, Kyoto Prefectural University of Medicine, Japan, and Director and Professor, Japan Institute for Food Education and Health, St. Agnes’ University. He was awarded “Vebleo Nanomedicine Scientist Award” (Sweden), “Marco Polo della Scienza Italiana” (Italy), The Premier's Research Excellence Award (Canada), Scholar Award (Medical Research Council of Canada) and Research Award from National Kidney Foundation of USA. He has obtained more than 60 research grants, published more than 250 peer reviewed articles, and provided more than 30 invited plenary lectures at international congresses and research conferences. h-index 40, i10-index 161, Citation 5714
Dr. Pan is a Senior Research Fellow at Menzies Institute for Medical Research. He has been researching both epidemiology and clinical interventions to osteoarthritis-related pain. Much of his work has been on identifying biomechanical risk factors for chronic pain and osteoarthritis, identifying pain and osteoarthritis phenotypes and testing new therapeutic treatments.
Associate Professor in Internal Medicine, Dept. Medicine, University of Padova, Italy.
International PhD Degree in 'Arterial Hypertension and Vascular Biology'.
Field of interest: Clinical and translational research in high blood pressure and cardiovascular diseases.
Dr. Rajesh Kumar Singh was born in 1980. He received his B. Pharmacy (2003) and M. Pharmacy (2005) from UIPS, Panjab University, Chandigarh. He completed his PhD in 2013 from IKG Punjab Technical University (IKGPTU), Jalandhar.
Dr. Singh’s major area of research interests are synthetic medicinal chemistry, polymer-drug conjugates for targeted delivery, Antimalarial and CNS active therapeutic agents and green chemistry approaches for chemical synthesis of pharmaceutical molecules.
Dr. Singh has over 14 years of teaching experience, guided 18 PG and 01 Ph.D. students and currently guiding 02 PhD students. He has published more than 60 peer-reviewed scientific research papers in SCI indexed various Chemistry and Pharmacy Journals of impact factor 1.5 to 4.8 as the main or corresponding author.
Dr. Singh is Editorial Board Member of SCOPUS indexed 06 Int. Journals. He has received Publon Award 2016, 2017 and Publon “Excellent Peer Reviewer award” for outstanding reviewing more than 120 research papers of different International Journals of ACS, RSC, Springer, Elsevier, Dove, Informa and Bentham of Impact Factor varies from 1.0 to 8.5. He has also to his credit more than 50 National and International Conference Abstracts, 2 Books, 5 Best Paper Presentation Awards, 1 Travel grant to attend Int. Conf. and 5 Research Projects funded by various government funding agencies.
Dr Bernhard Wernly is a Physician-scientist at the Paracelsus Medical University, Salzberg, Austria. He is trained in cardiology and intensive care medicine, MD, PhD and currently doing a Master in Public Health.